Heterotrimeric G protein signaling outside the realm of seven transmembrane domain receptors.
Heterotrimeric G proteins, consisting of the guanine nucleotide-binding Galpha subunits with GTPase activity and the closely associated Gbeta and Ggamma subunits, are important signaling components for receptors with seven transmembrane domains (7TMRs). These receptors, also termed G protein-coupled receptors (GPCRs), act as guanine nucleotide exchange factors upon agonist stimulation. There is now accumulating evidence for noncanonical functions of heterotrimeric G proteins independent of 7TMR coupling. Galpha proteins belonging to all 4 subfamilies, including G(s), G(i), G(q), and G(12) are found to play important roles in receptor tyrosine kinase signaling, regulation of oxidant production, development, and cell migration, through physical and functional interaction with proteins other than 7TMRs. Association of Galpha with non-7TMR proteins also facilitates presentation of these G proteins to specific cellular microdomains. This Minireview aims to summarize our current understanding of the noncanonical roles of Galpha proteins in cell signaling and to discuss unresolved issues including regulation of Galpha activation by proteins other than the 7TMRs.
Marty
Caroline
C
Institut National de la Santé et de la Recherche Médicale, Université Paris XI, Institut Gustave Roussy, Villejuif, France.
Ye
Richard D
RD
D000818:Animals; D020962:Heterotrimeric GTP-Binding Proteins / Q000187:drug effects / Q000378:metabolism* / Q000502:physiology; D006801:Humans; D020794:Receptor Protein-Tyrosine Kinases / Q000378:metabolism; D015398:Signal Transduction
D020794:Receptor Protein-Tyrosine Kinases; D020962:Heterotrimeric GTP-Binding Proteins
Neurosignals. 2002 Jan-Feb;11(1):5-19
11943878
J Clin Invest. 2002 May;109(9):1133-7
11994400
J Cell Biol. 2009 Mar 23;184(6):909-21
19307601
Trends Pharmacol Sci. 2007 Dec;28(12):602-7
18001849
Pharmacol Ther. 2007 Mar;113(3):488-506
17240454
J Biol Chem. 1997 Apr 11;272(15):10135-43
9092559
Immunity. 2009 May;30(5):708-20
19409815
J Biol Chem. 1997 Feb 28;272(9):5413-20
9038141
Nature. 1999 Dec 23-30;402(6764):884-8
10622253
Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):16077-82
14673086
Annu Rev Cell Dev Biol. 1997;13:513-609
9442882
J Biol Chem. 1999 Nov 19;274(47):33202-5
10559191
J Biol Chem. 2002 Oct 18;277(42):39493-8
12183468
Blood. 1988 May;71(5):1187-95
3129045
Blood. 1995 Sep 1;86(5):1776-83
7655008
J Biol Chem. 2007 Sep 28;282(39):28549-28556
17664271
J Biol Chem. 2004 Dec 31;279(53):54983-6
15525651
J Biol Chem. 2001 Nov 23;276(47):44037-43
11546809
J Biol Chem. 1988 Sep 5;263(25):12333-41
3137226
Cell. 1991 Nov 15;67(4):723-30
1657404
Nature. 1995 Aug 31;376(6543):781-4
7651538
Trends Neurosci. 2004 Jan;27(1):48-53
14698610
Growth Factors. 1993;8(1):41-8
8383515
Trends Pharmacol Sci. 2007 Aug;28(8):416-22
17644195
Mol Cell Biol. 1999 Oct;19(10):6765-74
10490615
Biochem Biophys Res Commun. 2005 Nov 18;337(2):615-20
16202387
Cell. 2003 Jul 25;114(2):201-14
12887922
J Biol Chem. 2006 Sep 8;281(36):26483-90
16787920
Annu Rev Biochem. 1987;56:615-49
3113327
Oncogene. 2006 Apr 6;25(15):2234-44
16301993
J Biol Chem. 1995 Jul 14;270(28):16495-8
7622449
J Biol Chem. 1991 Jul 15;266(20):13342-9
1649188
J Biol Chem. 1996 Mar 22;271(12):6947-51
8636123
Adv Exp Med Biol. 1989;254:101-12
2554695
Cell. 1990 Aug 24;62(4):709-17
2167177
J Biol Chem. 2001 Jan 19;276(3):2007-14
11053408
Sci Signal. 2009 Apr 28;2(68):ra17
19401591
Curr Biol. 2008 Feb 12;18(3):211-5
18261907
J Biol Chem. 2003 Mar 7;278(10):8356-62
12509430
FASEB J. 1999 Oct;13(13):1699-710
10506573
Endocr Rev. 2003 Dec;24(6):765-81
14671004
Circ Res. 2004 Apr 30;94(8):1032-40
15016732
Science. 1996 Feb 23;271(5252):1128-31
8599092
J Neurosci. 2006 Jan 11;26(2):585-96
16407557
Shock. 2004 Jul;22(1):57-62
15201703
Blood. 1989 Feb;73(2):588-91
2537115
Nature. 1995 May 18;375(6528):247-50
7746328
J Biol Chem. 2000 Aug 25;275(34):26206-12
10816569
Science. 2001 Mar 23;291(5512):2408-11
11264536
J Cell Sci. 2002 Feb 1;115(Pt 3):455-65
11861753
Cell. 2006 Jul 14;126(1):191-203
16839886
J Biol Chem. 1988 Oct 5;263(28):14093-8
2844756
EMBO J. 1998 Mar 2;17(5):1192-9
9482716
J Biol Chem. 1990 Dec 5;265(34):21317-22
2123491
J Biol Chem. 2005 Aug 26;280(34):30236-41
15972823
Methods Mol Biol. 2006;332:51-77
16878685
Nature. 1996 Feb 8;379(6565):557-60
8596637
Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3178-83
19211784
Science. 2010 Jan 15;327(5963):340-3
20075254
J Clin Invest. 1998 Dec 1;102(11):2019-27
9835628
J Biol Chem. 2000 Nov 17;275(46):35920-5
10969069
Science. 1997 Jan 24;275(5299):533-6
8999798
Biochem J. 1996 May 15;316 ( Pt 1):87-91
8645237
EMBO J. 1990 Aug;9(8):2423-8, 2389
2196173
Biochem J. 1993 May 15;292 ( Pt 1):183-7
8503845
Pathophysiology. 2010 Apr;17(2):89-99
19501489
Nature. 1998 Apr 9;392(6676):626-30
9560162
Trends Cardiovasc Med. 2000 Feb;10(2):81-9
11150735
J Immunol. 1995 Jul 1;155(1):181-9
7602094
J Biol Chem. 1995 Jun 30;270(26):15693-701
7797570
J Immunol. 1987 Dec 1;139(11):3604-13
2824610
Mol Cell Biol. 2006 Jul;26(13):5190-200
16782902
Cold Spring Harb Symp Quant Biol. 1989;54 Pt 2:733-40
2561805
Curr Biol. 2002 Aug 6;12(15):1353-8
12176367
J Biol Chem. 2002 Sep 6;277(36):32409-12
12117999
Proc Natl Acad Sci U S A. 2006 Nov 21;103(47):17789-94
17095603
Mol Cell Biol. 2003 Jun;23(11):3847-58
12748287
Dev Cell. 2006 Jun;10(6):707-18
16740474
J Biol Chem. 1990 Aug 25;265(24):14176-86
2117607
Pharmacol Rev. 2004 Sep;56(3):371-85
15317909
Proc Natl Acad Sci U S A. 2001 Jan 16;98(2):519-24
11136230
J Biol Chem. 2004 Nov 19;279(47):49406-13
15339924
Science. 1986 Nov 7;234(4777):743-6
3095921